Klotho通过调控铁死亡和逆转DNA甲基化抑制ADPKD囊肿生长
本研究探讨Klotho在常染色体显性多囊肾病(ADPKD)中的作用机制。在人类ADPKD肾脏、Pkd1突变细胞和小鼠模型中,Klotho表达显著降低;给予重组Klotho可减轻囊肿负荷、肾增大和血尿素氮水平,并抑制增殖、促进凋亡。机制上,Klotho抑制AKT、STAT3、Rb等信号通路,减轻炎症和纤维化,并通过上调GPX-4抑制铁死亡;ADPKD中DNMT1介导Klotho启动子高甲基化导致其沉默,抑制DNMT1可恢复Klotho表达,形成负反馈环路。结论:Klotho表观遗传抑制是ADPKD的关键环节,恢复Klotho信号可减缓疾病进展。
要点
- ADPKD中Klotho表达显著降低,与囊肿生长、炎症和纤维化相关。
- 重组Klotho可减轻Pkd1突变小鼠囊肿负荷和肾增大,降低血尿素氮。
- Klotho通过抑制铁死亡和逆转DNMT1介导的甲基化沉默发挥肾脏保护作用。
核心结论
- Klotho在ADPKD中因DNMT1介导的启动子高甲基化而被表观遗传沉默,恢复Klotho信号可显著减缓Pkd1突变小鼠的疾病进展。
研究设计与样本
- 研究分析了人类ADPKD肾脏、公共bulk和单细胞RNA-seq数据集、Pkd1突变肾上皮细胞及Pkd1小鼠模型,并在晚发型Pkd1fl/fl: tamoxifen-Cre小鼠中评估重组Klotho的治疗效果。
主要发现
- Klotho表达在人类ADPKD肾脏、Pkd1缺陷细胞和小鼠中显著降低,尤其在远端肾单位节段。
- 重组Klotho治疗显著减少囊肿负荷、肾脏增大和血尿素氮水平,同时减少上皮增殖并增加囊肿衬里细胞凋亡。
- Klotho抑制PKD相关信号通路(包括AKT、STAT3和Rb),通过下调Smyd2减少NF-κB介导的炎症,并减弱TGF-β-Smad依赖性肾纤维化。
- Klotho通过上调GPX-4和减少脂质过氧化抑制铁死亡。
- 表观遗传分析显示ADPKD肾脏中DNMT1介导Klotho启动子和基因体高甲基化,抑制DNMT1可恢复Klotho表达,而重组Klotho降低DNMT1水平,提示负反馈环路。
临床怎么用
- Klotho-DNMT1轴是ADPKD的潜在治疗靶点,恢复Klotho信号可能减缓囊肿生长和肾衰竭进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth, inflammation, fibrosis, and renal failure. Klotho is a renoprotective protein with anti-proliferative, anti-inflammatory, and antioxidant properties, but its mechanistic role in ADPKD remains poorly defined. METHODS: Klotho expression was analyzed in human ADPKD kidneys, public bulk and single-cell RNA-seq datasets, Pkd1 mutant renal epithelial cells, and Pkd1 mouse models. The therapeutic effects of recombinant Klotho were evaluated in late-onset Pkd1fl/fl: tamoxifen-Cre mice. Molecular mechanisms were investigated using cell viability assays, Western blotting, RT-qPCR, immunohistochemistry, ferroptosis assays, DNA methylation analysis, chromatin immunoprecipitation assay. RESULTS: Klotho expression was markedly reduced in human ADPKD kidneys and Pkd1-deficient cells and mice, particularly in distal nephron segments. Recombinant Klotho treatment significantly reduced cyst burden, kidney enlargement, and blood urea nitrogen levels, while decreasing epithelial proliferation and increasing apoptosis in cyst-lining cells. Mechanistically, Klotho suppressed PKD-associated signaling pathways, including AKT, STAT3, and Rb, reduced NF-κB-mediated inflammation via downregulation of Smyd2, and attenuated TGF-β-Smad-dependent renal fibrosis. Klotho also inhibited ferroptosis by upregulating GPX-4 and reducing lipid peroxidation. Epigenetic analyses revealed DNMT1-mediated hypermethylation of the Klotho promoter and gene body in ADPKD kidneys, contributing to Klotho silencing. Inhibition of DNMT1 restored Klotho expression, and recombinant Klotho reduced DNMT1 levels, suggesting a negative feedback loop. CONCLUSIONS: Klotho is epigenetically repressed in ADPKD and functions as a central regulator of cyst growth, inflammation, fibrosis, and ferroptosis. Restoration of Klotho signaling markedly attenuates disease progression in Pkd1 mutant mice, identifying the Klotho-DNMT1 axis as a promising therapeutic target for ADPKD.
引用
- Lv J, Xue C, Li LX, et al. Klotho suppresses cyst growth in ADPKD through the regulation of ferroptosis and reversing DNA methylation. Nephrol Dial Transplant. 2026. PMID: 42314074. doi:10.1093/ndt/gfag141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。